• menu shortcut
  • contents shortcut
SK biopharmaceuticals
    • CEO Message
    • Vision & Mission
    • History
    • Our Business
    • Network
    • Pipeline Products
    • R&D
    • Key Technologies
    • Startegic Alliance
    • Advisory Board
    • Business Area
    • Key Technologies
    • Career in SK BP
    • Recruiting Board
  • Korean
  • Contact us
  • What's new
  • Sitemap

what's New



Find out more about SK biopharmaceuticals with the latest news.

What's new
no title date
16 SK Biopharmaceuticals Enters Into A Collaboration Agreement to Study Lou Gehrig's Disease 2011.09.21
15 Establishment of SK biopharmaceuticals, Life Science Specialty Company of SK Group 2011.04.04
14 SK Holdings Announces U.S. FDA's Acceptance of IND for YKP10811 and SKL-N05 2010.01.12
13 SK Holdings Announces U.S. FDA's Approval of IND for SKL10406 2009.12.16
12 Depression project, won in the government fund by the Ministry of health, welfares and family affairs in Korea 2009.01.14
11 Johnson & Johnson Pharmaceutical Research & Development, L.L.C. submits New Drug Application to FDA for Carisbamate 2008.10.24
10 SK Corporation Announces Another IND, Schizophrenia Drug YKP1358 2007.05.07
9 SK Pharma Signs Contract with Arrow of US to Supply Omed 2007.05.07
8 Interview with Director of Sales, Fine Chemicals and Pharmaceuticals, SK Energy & Chemical, Inc. 2007.05.07
7 SK Corporation Announces Selection of Additional Candidate for Drug Evaluation Process in Scientific Collaboration with Johnson & Johnson 2007.05.07
first prev   1 . 2 . 3   next last

What's New

Quick Search

SK biopharmaceuticals

copyright (C) 2011 by SK biopharmaceuticals co. LTD. all rights reservied.